A judge temporarily blocked federal prosecutors in Texas from getting access to the medical records of transgender patients ...

Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...

The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing ...

The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood ...

With the right structure, Americans will roll up their sleeves, do the science, and trust the result,” Manoush Zomorodi ...

Eli Lilly is investing in a small startup developing a medication to spur hair growth, and potentially also treat endometriosis.

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and ...

Casey’s reporting examines the use of artificial intelligence by providers and insurers. It is one of the oldest mysteries in medicine: Why do fundamentally healthy people drop dead? Sudden cardiac ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every ...

Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental ...

Pfizer disclosed that an experimental lung cancer drug it hoped could replace a widely used chemotherapy fell short in a clinical trial, STAT writes. Expectations had been high that the drug, ...